Back to search

Aristotle University Of Thessaloniki (AUTH)

Ανίχνευση - ανάλυση πολυμορφισμών και μεταλλάξεων των γονιδίων TAU, GSK3B και LRRK2 σε ασθενείς με νόσο Parkinson από τη Β. Ελλάδα

Abstract

dc:description

Parkinson's disease (PD) is the second most common neurodegenerative disorder affecting approximately 1-2% of the population >65 years of age. Although, the etiology of PD is still unknown, the genetic background of the disease has been documented. The aim of the present study was to further investigate the genetic background of sporadic PD by studying genetic polymorphisms/mutations in tau, GSK3beta and LRRK2 genes. To determine whether polymorphisms in the tau and/or GSK3beta genes underpin susceptibility to Parkinson's disease (PD), we conducted a case-control association study in a Greek cohort of 196 PD cases and 163 healthy controls. In our study, the MAPT H1 haplotype was represented by the 238 bp insertion/deletion (I/D) polymorphism in intron 9 of the tau gene which was determined by PCR analysis. Tau rs242562 and tau rs2435207 polymorphisms were also studied as part of MAPT H1 haplotype by using the PCR&RFLP method. The PCR&RFLP method was also used for the examination of the rs334558 and rs6438552 polymorphisms in GSK3beta gene and the G2019S mutation in the LRRK2 gene. Comparison of genotype and haplotype frequency distributions, in patients and controls, was done with the χ² test, whereas haplotype analysis was carried out with the use of Haplo.score and PHASE ver.2.1 programmes. In our study, the MAPT H1 haplotype was found to be significantly associated with PD (Ρ=0,003). The subhaplotype G-A of tau rs242562 και rs2435207 was also overrepresented in PD patients compared to controls (P=0,017). No association was detected between the rs6438552 GSK3beta polymorphism and PD, whereas the C/C genotype of the rs334558 GSK3beta polymorphism was found to exert a protective role (Ρ=0,0005). Haplotype analysis revealed that, the T-T haplotype of both GSK3beta polymorphisms was over-represented in PD patients compared to controls (P=0,001), and this association was independent of MAPT H1 haplotype. G2019S Lrrk2 mutation was not found in our study. Tau seems to be implicated in the pathogenesis of many neurodegenerative diseases, including Parkinson’s disease. In the present study, the tau H1 haplotype was significantly associated with PD. Importantly, the tau H1 haplotype has been associated with increased tau expression. Increased expression and accumulation of tau is believed to be pathogenic and neurotoxic. Tau kinases, such as GSK3beta, seem to have an important role in tau neurotoxicity, as phosphorylation of tau results to its accumulation. In the present study, the T-T haplotype of GSK3beta polymorphisms was overrepresented in PD patients, highlighting a potential genetic role of GSK3beta in sporadic PD. As far as the G2019S LRRK2 mutation is concerned it is not common in the Greek population, enhancing the need to screen different populations in order to estimate the frequency of this mutation globally.

Degree

thesis:*
Grantor dc:publisher
Aristotle University Of Thessaloniki (AUTH)
Year dc:date
2010

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Kalinderi, Kallirhoe
  • Καλινδέρη, Καλλιρρόη

Subjects

dc:subject × 20

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/26966

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Kalinderi, Kallirhoe; Καλινδέρη, Καλλιρρόη. Ανίχνευση - ανάλυση πολυμορφισμών και μεταλλάξεων των γονιδίων TAU, GSK3B και LRRK2 σε ασθενείς με νόσο Parkinson από τη Β. Ελλάδα. Aristotle University Of Thessaloniki (AUTH), 2010. http://hdl.handle.net/10442/hedi/26966